Description

Sermorelin + Ipamorelin Blend Vials

Sermorelin + Ipamorelin Blend contains 5mg of Sermorelin and 5mg of Ipamorelin, totaling 10mg.

Sermorelin
CAS Number	86168-78-7
Molar Mass	3357.93 g·mol−1
Chemical Formula	C149H246N44O42S
IUPAC Name	L-Tyrosyl-L-alanyl-L-α-aspartyl-L-alanyl-L-isoleucyl-L-phenylalanyl-L-threonyl-L-asparaginyl-L-seryl-L-tyrosyl-L-arginyl-L-lysyl-L-valyl-L-leucylglycyl-L-glutaminyl-L-leucyl-L-seryl-L-alanyl-L-arginyl-L-lysyl-L-leucyl-L-leucyl-L-glutaminyl-L-α-aspartyl-L-isoleucyl-L-methionyl-L-seryl-L-argininamide

Ipamorelin
CAS number	170851-70-4
Molar Mass	711.868 g·mol−1
Chemical Formula	C38H49N9O5
IUPAC Name	(2S)-6-Amino-2-[[(2R)-2-[[(2R)-2-[[(2S)-2-[(2-amino-2-methylpropanoyl)amino]-3-(4H-imidazol-4-yl)propanoyl]amino]-3-naphthalen-2-ylpropanoyl]amino]-3-phenylpropanoyl]amino]hexanamide

Introduction

The Sermorelin + Ipamorelin Blend is a research peptide combination developed exclusively for scientific investigation. Engineered to explore potential synergies and applications in growth hormone regulation, this blend provides researchers with a tool to delve into physiological processes related to growth hormones.

Key Characteristics

Sermorelin is a growth hormone-releasing peptide designed to stimulate the body’s natural production of growth hormone. Ipamorelin is known for its growth hormone-stimulating properties, Ipamorelin complements Sermorelin in this blend.

Research Applications

This research peptide blend is formulated for investigations into growth hormone-related processes. Researchers may utilize it to explore potential synergistic effects and understand its impact on various physiological aspects.

Research Benefits

Potential for Synergistic Benefit

Studies may focus on the combined effects of Sermorelin and Ipamorelin, exploring potential synergies in stimulating growth hormone release.

Sermorelin and GH

Researchers may investigate the specific impact of Sermorelin on growth hormone production, contributing to a deeper understanding of its regulatory mechanisms.

Ipamorelin and Weight Gain

The research may delve into Ipamorelin’s potential impact on weight gain, providing insights into its applications for metabolic processes.

Summary

The Sermorelin + Ipamorelin Blend is a research peptide combination engineered for scientific exploration into growth hormone-related processes. With a focus on potential synergistic benefits, researchers are encouraged to investigate its effects on growth hormone stimulation, metabolic aspects, and more.

Disclaimer

This content is presented exclusively for educational purposes and should not be construed as medical advice. THE MATERIALS REFERENCED HEREIN ARE EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH USE.

Any clinical research initiatives must be conducted under the guidance of the relevant Institutional Review Board (IRB). Similarly, preclinical research involving animals must comply with the directives of the Institutional Animal Care and Use Committee (IACUC), adhering to the standards delineated by the Animal Welfare Act (AWA).

Our informational content is meticulously designed for research-oriented insights and is not a substitute for individual analysis and verification from credible sources before any purchasing decisions are made.

Upon finalizing your order and payment, you explicitly acknowledge and agree to adhere to our Terms and Conditions. Customer contentment stands as our paramount concern. If you are dissatisfied with the product received, kindly contact us at 419-707-5450 or email our support team at [email protected].

IMPORTANT NOTICE: All products showcased on our platform are EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH APPLICATIONS. They are expressly not intended for veterinary or human utilization.

References

1. Lall S, Tung LY, Ohlsson C, Jansson JO, Dickson SL. Growth hormone (GH)-independent stimulation of adiposity by GH secretagogues. Biochem Biophys Res Commun. 2001 Jan 12;280(1):132-8. doi: 10.1006/bbrc.2000.4065. PMID: 11162489. [Read More].
2. Corpas E, Harman SM, Piñeyro MA, Roberson R, Blackman MR. Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men. J Clin Endocrinol Metab. 1992 Aug;75(2):530-5. doi: 10.1210/jcem.75.2.1379256. PMID: 1379256. [Read More].